Research graph
References from Empirical transition probability modeling of continuous glucose monitoring data. Local targets link to admitted publications; unresolved targets remain external evidence.
Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range
10.2337/dci19-0028 · 2019 · External reference
International consensus on use of continuous glucose monitoring
10.2337/dc17-1600 · 2017 · External reference
Glycemic variability in diabetes: clinical and research implications
2018 · External reference
Continuous glucose monitoring: Current use and future directions
2020 · External reference
Continuous glucose monitoring in youth with diabetes: Evidence, opportunities, and challenges
2019 · External reference
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
10.1056/nejm199309303291401 · 1993 · External reference
Validation of time in range as an outcome measure for diabetes clinical trials
10.2337/dc18-1444 · 2019 · External reference
Interpretation of continuous glucose monitoring data: Glycemic variability and quality of glycemic control
10.1089/dia.2009.0077 · 2009 · External reference
The fallacy of average: How using HbA1c alone to assess glycemic control can be misleading
10.2337/dc17-0636 · 2017 · External reference
Glycemic variability: it’s not just about A1C anymore
10.1089/dia.2005.7.780 · 2005 · External reference
Time in range is associated with incident diabetic retinopathy in adults with Type 1 diabetes: A longitudinal study
10.1089/dia.2023.0486 · 2024 · External reference
The Virtual DCCT: Adding continuous glucose monitoring to a landmark clinical trial for prediction of microvascular complications
10.1089/dia.2024.0404 · 2025 · External reference
Glycemic variability: Adverse clinical outcomes and how to improve it?
10.1186/s12933-020-01085-6 · 2020 · External reference
A glycemia risk index (GRI) of hypoglycemia and hyperglycemia for continuous glucose monitoring validated by clinician ratings
10.1177/19322968221085273 · 2023 · External reference
Mean amplitude of glycemic excursions, a measure of diabetic instability
10.2337/diab.19.9.644 · 1970 · External reference
Day-to-day variation of continuously monitored glycaemia: A further measure of diabetic instability
10.1007/bf01218495 · 1972 · External reference
Translating glucose variability metrics into the clinic via Continuous Glucose Monitoring: A graphical user interface for diabetes evaluation (CGM-GUIDE©)
10.1089/dia.2011.0099 · 2011 · External reference
Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes
10.1001/jama.295.14.1681 · 2006 · External reference
Glucose variability: Timing, risk analysis, and relationship to hypoglycemia in diabetes
10.2337/dc15-2035 · 2016 · External reference
Glycemic Variability metrics and their role in predicting hypoglycemia risk
2020 · External reference
Novel Detection and Progression Markers for Diabetes Based on Continuous Glucose Monitoring Data Dynamics
10.1210/clinem/dgae379 · 2024 · External reference
An analytical approach to determine the optimal duration of continuous glucose monitoring data required to reliably estimate time in hypoglycemia
10.1038/s41598-020-75079-5 · 2020 · External reference
Continuous blood glucose monitoring: a bayes-hidden markov approach
2013 · External reference
Unresolved reference
2023 · External reference
A Markov model for inferring event types on diabetes patients data
10.1016/j.health.2022.100024 · 2022 · External reference
Bionic Pancreas for the Management of Type 1 Diabetes
2022 · External reference
Positive impact of the bionic pancreas on diabetes control in youth 6-17 years old with type 1 Diabetes: A multicenter randomized trial
10.1089/dia.2022.0201.pub · 2022 · External reference
A multicenter randomized trial evaluating the insulin-only configuration of the bionic pancreas in adults with Type 1 diabetes
10.1089/dia.2022.0200 · 2022 · External reference
Utilizing the ambulatory glucose profile to standardize and implement continuous glucose monitoring in clinical practice
10.1089/dia.2019.0034 · 2019 · External reference
A comparison of continuous glucose monitoring-measured time-in-range 70-180 mg/dL versus time-in-tight-range 70-140 mg/dL
10.1089/dia.2023.0380 · 2024 · External reference
Time in range is associated with incident diabetic retinopathy in adults with type 1 Diabetes: A longitudinal study
10.1089/dia.2023.0486 · 2024 · External reference
A tutorial on hidden Markov models and selected applications in speech recognition
10.1109/5.18626 · 1989 · External reference
Imputation of missing continuous glucose monitor data
10.1177/19322968241308217 · 2026 · External reference
Unresolved reference
2019 · External reference
The Statistical Analysis of Compositional Data
10.1111/j.2517-6161.1982.tb01195.x · 1982 · External reference
Markov models for community dynamics allowing for observation error
10.1890/12-1540.1 · 2013 · External reference
Exact and asymptotically robust permutation tests
10.1214/13-aos1090 · 2013 · External reference
